H van Baar1, M J L Bours2, S Beijer3, M van Zutphen1, F J B van Duijnhoven1, D E Kok1, E Wesselink1, J H W de Wilt4, E Kampman1, R M Winkels5. 1. Division of Human Nutrition and Health, Wageningen University & Research Wageningen, PO Box 17, 6700 AA, Wageningen, The Netherlands. 2. Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. 3. Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. 4. Department of Surgery, Radboud Universitair Medisch Centrum, Nijmegen, The Netherlands. 5. Division of Human Nutrition and Health, Wageningen University & Research Wageningen, PO Box 17, 6700 AA, Wageningen, The Netherlands. renate.winkels@wur.nl.
Abstract
PURPOSE: Persistent fatigue among colorectal cancer (CRC) patients might be associated with unfavorable body composition, but data are sparse and inconsistent. We studied how skeletal muscle index (SMI), skeletal muscle radiodensity (SMR), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) at diagnosis are associated with fatigue up to 24 months post-diagnosis in stage I-III CRC patients. METHODS: SMI, SMR, VAT, and SAT were assessed among 646 CRC patients using pre-treatment computed tomography images. Fatigue at diagnosis, at 6, and 24 months post-diagnosis was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire. The association of SMI, SMR, VAT, and SAT with fatigue (yes/no) was assessed using confounder-adjusted restricted cubic spline analyses. RESULTS: Prevalence of fatigue at diagnosis was 18%, at 6 months 25%, and at 24 months 12%. At diagnosis, a significant (p = 0.01) non-linear association of higher levels of SAT with higher prevalence of fatigue was observed. Lower levels of SMR were linearly associated with higher prevalence of fatigue at 6 months post-diagnosis (overall association p = 0.02). None of the body composition parameters were significantly associated with fatigue at 24 months. CONCLUSION: Having more SAT was associated with more fatigue at diagnosis, while low levels of SMR were associated with more fatigue at 6 months post-diagnosis. IMPLICATIONS FOR CANCER SURVIVORS: Our results suggest that it may be interesting to investigate whether interventions that aim to increase SMR around the time of diagnosis may help to lower fatigue. However, more knowledge is needed to understand the mechanisms behind the association of SMR with fatigue.
PURPOSE: Persistent fatigue among colorectal cancer (CRC) patients might be associated with unfavorable body composition, but data are sparse and inconsistent. We studied how skeletal muscle index (SMI), skeletal muscle radiodensity (SMR), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) at diagnosis are associated with fatigue up to 24 months post-diagnosis in stage I-III CRCpatients. METHODS: SMI, SMR, VAT, and SAT were assessed among 646 CRCpatients using pre-treatment computed tomography images. Fatigue at diagnosis, at 6, and 24 months post-diagnosis was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire. The association of SMI, SMR, VAT, and SAT with fatigue (yes/no) was assessed using confounder-adjusted restricted cubic spline analyses. RESULTS: Prevalence of fatigue at diagnosis was 18%, at 6 months 25%, and at 24 months 12%. At diagnosis, a significant (p = 0.01) non-linear association of higher levels of SAT with higher prevalence of fatigue was observed. Lower levels of SMR were linearly associated with higher prevalence of fatigue at 6 months post-diagnosis (overall association p = 0.02). None of the body composition parameters were significantly associated with fatigue at 24 months. CONCLUSION: Having more SAT was associated with more fatigue at diagnosis, while low levels of SMR were associated with more fatigue at 6 months post-diagnosis. IMPLICATIONS FOR CANCER SURVIVORS: Our results suggest that it may be interesting to investigate whether interventions that aim to increase SMR around the time of diagnosis may help to lower fatigue. However, more knowledge is needed to understand the mechanisms behind the association of SMR with fatigue.
Authors: Jane T Hickok; Joseph A Roscoe; Gary R Morrow; Karen Mustian; Paul Okunieff; Christopher W Bole Journal: Cancer Date: 2005-10-15 Impact factor: 6.860
Authors: Kerry S Courneya; Kristina H Karvinen; Kristin L Campbell; Robert G Pearcey; George Dundas; Valerie Capstick; Katia S Tonkin Journal: Gynecol Oncol Date: 2005-05 Impact factor: 5.482
Authors: Charlotte S Oldenburg; Dorry Boll; Kim A H Nicolaije; M Caroline Vos; Johanna M A Pijnenborg; Jan-Willem Coebergh; Sandra Beijer; Lonneke V van de Poll-Franse; Nicole P M Ezendam Journal: Gynecol Oncol Date: 2013-01-05 Impact factor: 5.482
Authors: Matti Aapro; Florian Scotte; Thierry Bouillet; David Currow; Antonio Vigano Journal: Clin Colorectal Cancer Date: 2016-05-07 Impact factor: 4.481
Authors: Melissa S Y Thong; Floortje Mols; Xin S Wang; Valery E P P Lemmens; Tineke J Smilde; Lonneke V van de Poll-Franse Journal: Eur J Cancer Date: 2013-03-01 Impact factor: 9.162
Authors: P A J Vissers; M S Y Thong; F Pouwer; M M J Zanders; J W W Coebergh; L V van de Poll-Franse Journal: J Cancer Surviv Date: 2013-08-06 Impact factor: 4.442
Authors: Merel R van Veen; Floortje Mols; Martijn J L Bours; Matty P Weijenberg; Ellen Kampman; Sandra Beijer Journal: Support Care Cancer Date: 2019-03-29 Impact factor: 3.603
Authors: Alix G Sleight; Sylvia L Crowder; Jacek Skarbinski; Paul Coen; Nathan H Parker; Aasha I Hoogland; Brian D Gonzalez; Mary C Playdon; Steven Cole; Jennifer Ose; Yuichi Murayama; Erin M Siegel; Jane C Figueiredo; Heather S L Jim Journal: Cancers (Basel) Date: 2022-04-14 Impact factor: 6.575
Authors: Lonneke V van de Poll-Franse; Nicole Horevoorts; Dounya Schoormans; Sandra Beijer; Nicole P M Ezendam; Olga Husson; Simone Oerlemans; Sanne B Schagen; Geja J Hageman; Katrijn Van Deun; Corina van den Hurk; Mies van Eenbergen; Floortje Mols Journal: J Natl Cancer Inst Date: 2022-06-13 Impact factor: 11.816